Projects to develop decision support software for macular disease, sustained release ocular implants and a control sleeve for intravitreal injections are a step closer to commercial development, following the latest round of government research grants. Read more
Melbourne biopharmaceutical company Opthea has completed the patient recruitment phase for the latest trial of its novel therapy for diabetic macular edema (DME). Read more
New research has drawn a link between severe sleep apnoea and diabetic macular oedema, firming up the connection between the two conditions.
By combining archaea and mammal DNA, researchers are hoping to ‘bypass evolution’ and give people genes that would allow them to resist retinal degeneration.
Researchers have found cellular components in the epithelial tissue of the eye that were previously only thought to be present in electrically active tissues. It is hoped the discovery could lead to new treatments for diseases that are currently incurable.
A newly detailed model for cultivating retinal pigment cells could make the development of new and improved ocular drugs significantly easier. Read more
Scientists from Singapore and the United States have found new evidence suggesting a link between primary open angle glaucoma (POAG) and Alzheimer’s. Read more
An Australian-led study has received $5 million to undertake the world’s most intensive investigation into why a particular group of age-related macular degeneration (AMD) patients are at greater risk of vision loss. Read more
Inconsistent or ineffective age-related macular degeneration (AMD) treatments might be solved by an easy solution, according to new research from the California Institute of Technology. Read more
A large UK study has linked air pollution to increased rates of glaucoma, adding to a growing body of evidence suggesting environmental factors might add to development and progression of the disease.